227 related articles for article (PubMed ID: 26258678)
41. Effect of heart failure exacerbations on anticoagulation: a prospective, observational, pilot cohort study.
Ripley TL; Harrison D; Germany RE; Adamson PB
Clin Ther; 2010 Mar; 32(3):506-14. PubMed ID: 20399987
[TBL] [Abstract][Full Text] [Related]
42. Individual and monitoring centre influences upon anticoagulation control of AF patients on warfarin: A longitudinal multi-centre UK-based study.
Abohelaika S; Wynne H; Avery P; Robinson B; Jones L; Tait C; Dickinson B; Salisbury J; Nightingale J; Green L; Kamali F
Eur J Haematol; 2018 Oct; 101(4):486-495. PubMed ID: 29949204
[TBL] [Abstract][Full Text] [Related]
43. Efficacy and safety of a pharmacist-managed inpatient anticoagulation service for warfarin initiation and titration.
Wong YM; Quek YN; Tay JC; Chadachan V; Lee HK
J Clin Pharm Ther; 2011 Oct; 36(5):585-91. PubMed ID: 21070296
[TBL] [Abstract][Full Text] [Related]
44. Does telehealth improve anticoagulation management in patient service centers (PSC)? A pilot project.
Bernstein MR; John L; Sciortino S; Arambages E; Auletta D; Spyropoulos AC
J Thromb Thrombolysis; 2020 Feb; 49(2):316-320. PubMed ID: 31898275
[TBL] [Abstract][Full Text] [Related]
45. Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study.
Clark NP; Witt DM; Delate T; Trapp M; Garcia D; Ageno W; Hylek EM; Crowther MA;
Pharmacotherapy; 2008 Aug; 28(8):960-7. PubMed ID: 18657012
[TBL] [Abstract][Full Text] [Related]
46. Comparison of warfarin time in the therapeutic range at a pharmacist-run anticoagulation clinic and the RE-LY trial.
Biszewski M; Nitzki-George D; Zhou Y
Am J Health Syst Pharm; 2015 Apr; 72(7):557-62. PubMed ID: 25788509
[TBL] [Abstract][Full Text] [Related]
47. Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients.
Gallagher AM; Setakis E; Plumb JM; Clemens A; van Staa TP
Thromb Haemost; 2011 Nov; 106(5):968-77. PubMed ID: 21901239
[TBL] [Abstract][Full Text] [Related]
48. Prompt repeat testing after out-of-range INR values: a quality indicator for anticoagulation care.
Rose AJ; Hylek EM; Berlowitz DR; Ash AS; Reisman JI; Ozonoff A
Circ Cardiovasc Qual Outcomes; 2011 May; 4(3):276-82. PubMed ID: 21505156
[TBL] [Abstract][Full Text] [Related]
49. Quality of anticoagulation control and costs of monitoring warfarin therapy among patients with atrial fibrillation in clinic settings: a multi-site managed-care study.
Menzin J; Boulanger L; Hauch O; Friedman M; Marple CB; Wygant G; Hurley JS; Pezzella S; Kaatz S
Ann Pharmacother; 2005 Mar; 39(3):446-51. PubMed ID: 15701783
[TBL] [Abstract][Full Text] [Related]
50. Time outside of therapeutic range in atrial fibrillation patients is associated with long-term risk of dementia.
Jacobs V; Woller SC; Stevens S; May HT; Bair TL; Anderson JL; Crandall BG; Day JD; Johanning K; Long Y; Mallender C; Olson JL; Osborn JS; Weiss JP; Bunch TJ
Heart Rhythm; 2014 Dec; 11(12):2206-13. PubMed ID: 25111326
[TBL] [Abstract][Full Text] [Related]
51. Ischemic stroke and intracranial hemorrhage with aspirin, dabigatran, and warfarin: impact of quality of anticoagulation control.
Ho CW; Ho MH; Chan PH; Hai JJ; Cheung E; Yeung CY; Lau KK; Chan KH; Lau CP; Lip GY; Leung GK; Tse HF; Siu CW
Stroke; 2015 Jan; 46(1):23-30. PubMed ID: 25406148
[TBL] [Abstract][Full Text] [Related]
52. Quality of anticoagulation with warfarin across Kuwait.
Zubaid M; Saad H; Ridha M; Mohanan Nair KK; Rashed W; Alhamdan R; Alenezi F; Maghami M; Sadek A
Hellenic J Cardiol; 2013; 54(2):102-6. PubMed ID: 23557609
[TBL] [Abstract][Full Text] [Related]
53. A cross-sectional evaluation of five warfarin anticoagulation services in Uganda and South Africa.
Semakula JR; Mouton JP; Jorgensen A; Hutchinson C; Allie S; Semakula L; French N; Lamorde M; Toh CH; Blockman M; Sekaggya-Wiltshire C; Waitt C; Pirmohamed M; Cohen K
PLoS One; 2020; 15(1):e0227458. PubMed ID: 31995565
[TBL] [Abstract][Full Text] [Related]
54. [Anticoagulation in patients with atrial fibrillation].
Mügge A
Herz; 1996 Feb; 21(1):28-36. PubMed ID: 8647577
[TBL] [Abstract][Full Text] [Related]
55. Identifying potential predictors of high-quality oral anticoagulation assessed by time in therapeutic international normalized ratio range: a prospective, long-term, single-center, observational study.
Costa GL; Lamego RM; Colosimo EA; Valacio RA; Moreira Mda C
Clin Ther; 2012 Jul; 34(7):1511-20. PubMed ID: 22717417
[TBL] [Abstract][Full Text] [Related]
56. Impact of co-morbidities and patient characteristics on international normalized ratio control over time in patients with nonvalvular atrial fibrillation.
Nelson WW; Choi JC; Vanderpoel J; Damaraju CV; Wildgoose P; Fields LE; Schein JR
Am J Cardiol; 2013 Aug; 112(4):509-12. PubMed ID: 23800552
[TBL] [Abstract][Full Text] [Related]
57. The impact of new-onset cancer among veterans who are receiving warfarin for atrial fibrillation and venous thromboembolism.
Ambrus DB; Reisman JI; Rose AJ
Thromb Res; 2016 Aug; 144():21-6. PubMed ID: 27270218
[TBL] [Abstract][Full Text] [Related]
58. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation.
Hylek EM; Go AS; Chang Y; Jensvold NG; Henault LE; Selby JV; Singer DE
N Engl J Med; 2003 Sep; 349(11):1019-26. PubMed ID: 12968085
[TBL] [Abstract][Full Text] [Related]
59. Defining time in therapeutic range for busy clinicians: frequency of dose changes is a good surrogate marker to identify patients with suboptimal anticoagulation with warfarin.
Vijenthira A; Le Gal G; Castellucci LA; Carrier M
Thromb Res; 2014 Sep; 134(3):584-6. PubMed ID: 25037497
[TBL] [Abstract][Full Text] [Related]
60. Evaluating warfarin management by pharmacists in a community teaching hospital.
Chilipko AA; Norwood DK
Consult Pharm; 2014 Feb; 29(2):95-103. PubMed ID: 24513419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
